CLINICAL_TRIALS ClinicalTrials.gov record update

Phase I/II Study of BLU-451 in Advanced Cancers With EGFR Exon 20 Insertion Mutations

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT05241873
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-25T22:26:52.679195+00:00
Published At: 2025-02-10T00:00:00+00:00
Record Updated At: 2025-02-10
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Lung Neoplasm Malignant", "Carcinoma, Non-Small-Cell Lung", "Respiratory Tract Neoplasms", "Neoplasms", "Neoplasms by Site", "Lung Diseases", "Respiratory Tract Disease", "Carcinoma, Bronchogenic", "Bronchial Neoplasms", "Adenocarcinoma", "Carcinoma", "Neoplasms by Histologic Type", "EGFR Exon 20 Mutation", "EGFR Exon 20 Insertion Mutation", "EGFR Activating Mutation", "Antineoplastic Agents", "Metastatic Lung Cancer", "Brain Metastases", "EGFR-mutated NSCLC", "EGFR Atypical Mutations, Including G719X and L861Q"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2025-02-10"
protocolSection.identificationModule.nctId: "NCT05241873"
protocolSection.identificationModule.officialTitle: "Phase I/II Study of BLU-451 in Advanced Cancers With EGFR Exon 20 Insertion Mutations"
protocolSection.statusModule.overallStatus: "TERMINATED"
protocolSection.designModule.phases: ["PHASE1"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.